TRIAL IN PROGRESS: PHASE 1 DOSE-FINDING STUDY TO EVALUATE SAFETY AND TOLERABILITY OF CVGBM IN PATIENTS WITH NEWLY DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA

被引：0

作者：

Tabatabai, G. ^{[1
]}

von Baumgarten, L. ^{[2
]}

van den Bent, M. ^{[3
]}

Burger, M. C. ^{[4
,5
]}

Freres, P. ^{[6
]}

Glas, M. ^{[7
]}

Hau, P. ^{[8
]}

Herrlinger, U. ^{[9
]}

Mildenberger, I. ^{[10
]}

Neyns, B. ^{[11
]}

Schaefer, H. ^{[12
]}

Seidel, C. ^{[13
]}

de Vos, F. ^{[14
]}

Galot, R. ^{[15
]}

Whenham, N. ^{[15
]}

Wick, A. ^{[16
]}

Falk, M. ^{[17
]}

Chama, L. de Freitas ^{[18
]}

Henze, J. ^{[17
]}

Kelemen, P. ^{[17
]}

Koch, S. D. ^{[18
]}

Lutz, J. ^{[18
]}

Heidenreich, R. ^{[18
]}

Roche, P. Romer ^{[17
]}

Rost, T. ^{[17
]}

Schoenborn-Kellenberger, O. ^{[17
]}

Gnad-Vogt, U. ^{[17
]}

机构：

[1] Tubingen Univ Hosp, Tubingen, Germany

[2] Ludwig Maximilians Univ Munchen, Neurosurg Clin & Polyclin, Munich, Germany

[3] Erasmus MC Canc Inst, Rotterdam, Netherlands

[4] Goethe Univ Hosp, Frankfurt, Germany

[5] Hosp Frankfurt, Ctr Neurologsurg & Neurooncol, Frankfurt, Germany

[6] Liege Univ Hosp, Frankfurt, Germany

[7] Univ Med Essen, Essen, Germany

[8] Univ Hosp Regensburg, Regensburg, Germany

[9] Univ Bonn, Bonn, Germany

[10] Mannheim Univ, Med Ctr, Mannheim, Germany

[11] Univ Hosp Brussels, Brussels, Belgium

[12] Univ Freiburg, Freiburg, Germany

[13] Univ Hosp Leipzig, Frankfurt, Germany

[14] Univ Med Ctr Utrecht, Frankfurt, Germany

[15] Univ St Luc Hosp, Brussels, Belgium

[16] Heidelberg Univ Hosp, Heidelberg, Germany

[17] CureVac SE, Wiesbaden, Germany

[18] CureVac SE, Tubingen, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P06.09.B

引用

页码：47 / 47

页数：1

共 50 条

[1] Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.
Tabatabai, Ghazaleh
Von Baumgarten, Louisa
Van Den Bent, Martin J.
Burger, Michael C.
Freres, Pierre
Glas, Martin
Hau, Peter
Herrlinger, Ulrich
Mildenberger, Iris
Neyns, Bart
Schafer, Henning Sebastian
Seidel, Clemens
Galot, Rachel
Wick, Antje
Falk, Martin H.
Chama, Laura Leticia de Freitas
Kelemen, Peter
Koch, Sven D.
Roche, Paula Romer
Gnad-Vogt, Senta Ulrike
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[2] First in human study of the mRNA-based cancer vaccine CVGBM in patients (pts) with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma (GBM): First results from the dose escalation phase
Tabatabai, G.
Freres, P.
Glas, M.
Hau, P.
von Baumgarten, L.
van den Bent, M. J.
Burger, M. C.
Seidel, C.
Herrlinger, U.
Mildenberger, I.
Neyns, B.
Schafer, H.
Wick, A.
Falk, M. H.
Chama, L. L. de Freitas
Kelemen, P. G.
Schwenke, F.
Koch, S. D.
Roche, P. Romer
Gnad-Vogt, U. S.
ANNALS OF ONCOLOGY, 2024, 35 : S406 - S406
[3] FIRST IN HUMAN STUDY OF THE MRNA-BASED CANCER VACCINE CVGBM IN PATIENTS (PTS) WITH NEWLY-DIAGNOSED AND SURGICALLY RESECTED MGMT-UNMETHYLATED GLIOBLASTOMA (GBM): FIRST RESULTS FROM THE DOSE ESCALATION PHASE
Tabatabai, Ghazaleh
Freres, Pierre
Glas, Martin
Hau, Peter
von Baumgarten, Louisa
van den Bent, Martin
Burger, Michael C.
Seidel, Clemens
Herrlinger, Ulrich
Mildenberger, Iris
Neyns, Bart
Schafer, Henning
Wick, Antje
Falk, Martin
de Chama, Laura Leticia Freitas
Kelemen, Peter
Schwenke, Frauke
Koch, Sven D.
Roche, Paula Romer
Gnad-Vogt, Ulrike
NEURO-ONCOLOGY, 2024, 26
[4] PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA
Majd, Nazanin
Yeboa, D. Nana
Weathers, Shiao-Pei
Yuan, Ying
Robichaux, Christine
Al Anssari, Haider
Gachimova, Evguenia
Loghin, Monica
Kamiya-Matsuoka, Carlos
O'Brien, Barbara
Aaroe, Ashley
Patel, Chirag
Yung, W. K. Alfred
Wintermark, Max
Gule, Maria
Ferguson, Sherise
Puduvalli, Vinay
de Groot, John
NEURO-ONCOLOGY, 2023, 25
[5] PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA
Huang, Jiayi
Ahluwalia, Manmeet
Boockvar, John
Batiste, James
Jaboin, Jerry
Thotala, Dinesh
Halasz, Lia
Rammohan, Nikhil
Ney, Douglas
Malani, Rachna
Chinnaiyan, Prakash
Kotecha, Rupesh R.
Mehta, Minesh
Marcus, Stephen
NEURO-ONCOLOGY, 2024, 26
[6] Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma
Majd, Nazanin
Yeboa, Debra
Wang, Shuqi
Weathers, Shiao-Pei S.
Yuan, Ying
Al Anssari, Haider
Kamiya-Matsuoka, Carlos
O'Brien, Barbara Jane
Aaroe, Ashley
Patel, Chirag B.
Dagher, Samir
Wintermark, Max
Ferguson, Sherise D.
Puduvalli, Vinay K.
Liu, Siyuan John
Raleigh, David R.
de Groot, John Frederick
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[7] PHASE 1/2 STUDY OF DIANHYDROGALACTITOL (VAL-083) WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA
Chen, Zhong-ping
Guo, Chengcheng
Bacha, Jeffrey
Steino, Anne
Langlands, John
Kwan, Claire
Kanekal, Sarath
Schwartz, Richard
Lopez, Lorena
Brown, Dennis
NEURO-ONCOLOGY, 2018, 20 : 27 - 27
[8] PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA
Majd, Nazanin
Liu, John
Yeboa, Nana
Wang, Shuqi
Weathers, Shiao-Pei
Yuan, Ying
Gachimova, Evguenia
Wathoo, Chetna
Kamiya-Matsuoka, Carlos
O'Brien, Barbara
Aaroe, Ashley
Patel, Chirag
Patel, Anuj
Dagher, Samir
Wintermark, Max
Ferguson, Sherise
Puduvalli, Vinay
Raleigh, David
de Groot, John
NEURO-ONCOLOGY, 2024, 26
[9] A PHASE I STUDY OF EGFRVIII-DIRECTED CAR T CELLS COMBINED WITH PD-1 INHIBITION IN PATIENTS WITH NEWLY, DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA: TRIAL IN PROGRESS
Bagley, Stephen
Desai, Arati
Binder, Zev
Nasrallah, MacLean
Hwang, Wei-Ting
Maloney-Wilensky, Eileen
Prior, Timothy
Brem, Steven
O'Rourke, Donald
NEURO-ONCOLOGY, 2019, 21 : 221 - 221
[10] Phase I/II study of dianhydrogalactitol (VAL-083) with radiation therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma
Chen, Zhong-ping
Guo, Chengcheng
Bacha, Jeffrey
Langlands, John
Steino, Anne
Kwan, Claire
Kanekal, Sarath
Schwartz, Richard
Lopez, Lorena
Brown, Dennis
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →